Diamond Sponsors
Eli Lilly and Company is a leading American multinational pharmaceutical company founded in 1876 by pharmaceutical chemist Eli Lilly. Headquartered in Indianapolis, Indiana, Lilly has grown into one of the world’s most prominent research-based life sciences firms, dedicated to discovering, developing, manufacturing, and marketing innovative medicines that improve patient health and quality of life. With operations in numerous countries and a diverse global workforce, Lilly focuses its research on life-changing therapies across therapeutic areas including diabetes, obesity, oncology, autoimmune, and neurological conditions. The company is known for groundbreaking products such as Mounjaro, Zepbound, Trulicity, Verzenio, and others, addressing major health challenges worldwide. Lilly also provides access to care services and supports clinical research initiatives to advance medical science. Today, Lilly continues more than a century of innovation in healthcare, aiming to put health above all and expand its impact on patients around the globe.
Novartis is reimagining medicine to improve and extend people’s lives. As a leading global medicines company, we use innovative science and digital technologies to create transformative treatments in areas of great medical need. In our quest to find new medicines, we consistently rank among the world’s top companies investing in research and development. Novartis products reach more than 750 million people globally and we are finding innovative ways to expand access to our latest treatments. About 105,000 people of more than 140 nationalities work at Novartis around the world. For more information visit: www.novartis.com
Platinum Sponsors
AbbVie was founded in 2013 when we became a separate company from Abbott. Our name represents a proud connection to that legacy. AbbVie formed a new kind of enterprise – a biopharmaceutical company – with the stability, global scale, resources and commercial capabilities of a pharmaceutical company and the focus and culture of a biotech. Since the beginning, our mission hasn't wavered. Our combination of focused innovation and commercial scale brings differentiated products to market that benefit patients, customers and health care providers. Our mission is to discover and deliver innovative medicines and products that solve serious health issues and enhance people’s lives today and address the medical challenges of tomorrow.
We are an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people’s lives. Our teams across the world strive to transform the practice of medicine, turning the impossible into the possible for patients. We provide potentially life-changing treatments and the protection of life-saving vaccines to millions of people, and affordable access to our medicines in some of the world’s poorest countries.
Gold Sponsors
We’re in relentless pursuit of breakthroughs that change patients’ lives. We innovate every day to make the world a healthier place. It was Charles Pfizer's vision at the beginning and it holds true today. Our unique resources allow us to do more for people. Using our global presence and scale, we’re able to make a difference in local communities and the world around us. We advance medical innovation and distribute medicines that might not otherwise be available to underserved communities.
Everyone's skin is unique and we each have our own skin story. At Galderma, we embrace these differences and offer cutting-edge, premium brands that fit people's individual needs, across the full spectrum of dermatology through Injectable Aesthetics, Dermatological Skincare and Therapeutic Dermatology. https://www.galderma.com/
Silver Sponsors
We are an independent global healthcare company with a strategy to improve the health of women throughout their lives. Our diverse portfolio across women's health, biosimilars, and established brands includes therapies and products for a wide range of conditions and diseases. Our portfolio encompasses more than 70 medicines and devices across a range of areas including reproductive health, cardiovascular disease, neurology, dermatology, autoimmune, and respiratory conditions. We bring these important therapies to more than 140 markets around the world.
L’Oréal Group, founded in 1909 by French chemist Eugène Schueller and headquartered in Clichy, France, is the world’s leading beauty and cosmetics company, dedicated to delivering innovative, high-quality products for women and men globally. With a diverse portfolio spanning haircare, skincare, makeup, fragrance, and dermocosmetics, its brands—such as L’Oréal Paris, Lancôme, Garnier, Kérastase, and CeraVe—cater to mass-market, professional, and luxury segments in nearly 150 countries. Renowned for its commitment to research, innovation, sustainability, and inclusivity, L’Oréal combines scientific expertise with a vision of “beauty that moves the world”, making it an iconic leader in the beauty industry.
Pharmalink is a leading UAE-based healthcare organization with over 30 years of experience, dedicated to enhancing patient access to high-quality medical solutions across the GCC region. Their comprehensive portfolio includes pharmaceuticals, biosimilars, and branded generics, addressing diverse therapeutic areas such as rare disease , Neurology , gastroenterology, oncology, and cardiovascular health. By partnering with global healthcare innovators, Pharmalink continues to fulll its mission of improving community health outcomes. For more information visit: https://pharmalink.ae/
World-Class Quality, Efficacy & Excellence Jamjoom pharma is Leading pharmaceutical company with strong international presence, Operating currently in more than 35 countries with diversified portfolio. Millions of patients benefit from Jamjoom pharma Dermatological solutions yearly, through trusted portfolio leading different therapeutic categories. Jamjoom Pharma merges global best practices with local expertise to maximize value creation for key stakeholders and Health care partners, while reinforcing our position as a leading pharmaceutical manufacturing organization in the Middle East and Africa region.
Genpharm is a financially sound privately-owned company based in the Dubai Science Park (DSP), U.A.E. A specialty pharmaceutical company providing partners with fast-track market access and sustainable commercial solutions into the Middle East and North Africa (MENA) region and Turkey. We are the preferred regional commercial partner for rare genetic diseases, orphan drugs, and specialty therapeutics. We are the first organization to introduce gene therapy in the MENAT Region. We also provide strategic advice on disease areas, product launches, and go to markets strategies. We operate through evidence-based medicine and at the highest ethical standards. Genpharm is driven by a clear purpose. Our employees, associates, and partners take this to heart. It is apparent in our daily work, in every interaction within our communities and with every partnership we forge. We are #BringingCuresToMENATPatients. www.genpharmservices.com
Bronze Sponsors
NewBridge Pharmaceuticals, headquartered in Dubai, UAE, is a regional specialty company with a comprehensive pharmaceutical platform of services and expertise, established to bridge the access gap and partner with global pharma and biotech companies to in-license and commercialize U.S. FDA or EMA approved innovative therapeutics that address unmet medical needs into the Middle East and North Africa (MENA) regions.
We are an independent, research-based pharmaceutical company We are a global company dedicated to advancing the standard of care for the benefit of people with skin conditions, their families and society What we stand for - Our people are united worldwide with strong core values and a common vision Position and views - We support public policies that promote the discovery of innovative medicines and better accessibility to those who need them Our heritage - From humble beginnings in the basement of the Copenhagen LEO Pharmacy, we have now grown into a global leader in dermatology Our governance - Our proactive and transparent corporate governance structure promotes sustainable business behavior and long-term value creation
K-MENA is a regional healthcare platform dedicated to bridging the gap between global healthcare innovators and the patients in the Middle East and North Africa (MENA) region.
Proudly Australian owned, Ego Pharmaceuticals has led the way in the development, manufacture and marketing of innovative skincare products since our inception in 1953. We exist for people who want healthy skin, and are proud to be specialists in dermatological skincare that is backed by science. Our products are made in Australia for the people of the world, and are underpinned by Ego’s heritage and integrity. That’s why millions of people trust Ego to help care for their skin every day. https://www.egopharm.com/
Exhibitors
Oia Properties is a leading, award winning real estate agency operating in Abu Dhabi and Dubai, specializing in the sale and rental of residential properties and commercial spaces. Founded in 2021, with extensive experience in the Middle East and UAE real estate market, we have achieved remarkable milestones, rapidly growing into one of the region’s renowned top-selling agencies. As a trusted partner of leading UAE developers such as Aldar Properties, Modon, Emaar Properties, Binghatti, Meraas, Nakheel, DAMAC Properties, Bloom Holding, and many more, we continue to strengthen our presence by connecting clients with the finest real estate opportunities. Driven by a customer-centric approach, our team of expert consultants, market analysts, and investment strategists is dedicated to understanding and fulfilling each client's unique vision. Oia, a name was inspired by the breathtaking village of Oia in Santorini, Greece, known for its stunning sunsets, white-washed architecture, and timeless charm. Just like the island, Oia Properties embodies beauty, elegance, and a vision of extraordinary living. We bring this essence into the real estate experience, offering homes and investment opportunities that reflect sophistication, comfort, and long-term value. At Oia Properties, we connect people with properties that align with their vision, helping clients buy with confidence, make smart investments, and establish thriving commercial spaces. From the first consultation to closing the deal, we are committed to excellence at every step of the journey.
Our Purpose at Sandoz is clear: pioneering access for patients We focus on driving access to make a difference for patients and are already doing so in a very real way. How? We specialize in the development of generic and biosimilar medicines. That means we develop more affordable versions of high-quality medicines once their key patents have expired. For us, pioneering access for patients means going new ways in how we develop new products in line with patient needs, how we produce cutting-edge medicines at prices people can afford, and how we get the medicines to the patients who need them. As the leading supplier of such medicines – which account for around 80% of medicines worldwide – we make access to high-quality medicines more affordable. Why? Because medicines can only transform lives when they reach those who need them. While they can be powerful, originator medicines are often too expensive for many healthcare systems and patients. Developing off-patent medicines makes them more affordable and accessible. Going forward, we expect to make an even bigger difference to those who need affordable, sustainable and high-quality healthcare.